|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:acquired_by
|
gptkb:Danaher_Corporation
|
|
gptkbp:acquisition_year
|
gptkb:2015
|
|
gptkbp:awards
|
safety awards
various industry awards
sustainability awards
innovation awards
|
|
gptkbp:certification
|
gptkb:ISO_9001
gptkb:ISO_13485
FDA compliance
|
|
gptkbp:community_engagement
|
gptkb:Philanthropy
educational initiatives
volunteer programs
|
|
gptkbp:competitors
|
gptkb:Eaton_Corporation
gptkb:Thermo_Fisher_Scientific
gptkb:GE_Healthcare
gptkb:Sartorius_AG
gptkb:Merck_Millipore
|
|
gptkbp:employees
|
over 10,000
|
|
gptkbp:founded
|
1946
|
|
gptkbp:founder
|
David Pall
|
|
gptkbp:global_presence
|
operates in over 35 countries
|
|
gptkbp:headquarters
|
gptkb:Port_Washington,_New_York
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Pall Pharmaceutical
|
|
gptkbp:industry
|
healthcare
|
|
gptkbp:market
|
industrial applications
water treatment
biopharmaceuticals
food and beverage
|
|
gptkbp:parent_company
|
gptkb:Danaher_Corporation
|
|
gptkbp:partnerships
|
government agencies
research institutions
various universities
|
|
gptkbp:products
|
filtration systems
purification systems
separation systems
|
|
gptkbp:research_and_development
|
new technologies
product improvement
focus on innovation
|
|
gptkbp:revenue
|
approximately $3 billion
|
|
gptkbp:services
|
gptkb:biotechnology
pharmaceutical manufacturing
laboratory services
|
|
gptkbp:specialization
|
sterilization
air filtration
bioprocessing
liquid filtration
|
|
gptkbp:sustainability_initiatives
|
energy efficiency
waste reduction
water conservation
environmental responsibility
|
|
gptkbp:website
|
www.pall.com
|
|
gptkbp:bfsParent
|
gptkb:Pall_Life_Sciences
|
|
gptkbp:bfsLayer
|
5
|